Synagis® (Palivizumab) -- 7816
The supplier will provide Synagis® (Palivizumab) on an if and when requested basis, to the Ministry of Health, Acute and Emergency Services Branch at various (Saskatchewan Health Authority) locations throughout Saskatchewan.
No alternatives to Synagis® will be accepted.
No firm commitment of quantity can be given but the Ministry is estimating that approximately 1,800 units could be used during the course of this agreement. However, it should be noted that items identified may not necessarily be ordered. The supplier understands and acknowledges that the estimated usage specified is an estimate only, constituting an approximation made in good faith of the potential requirements. These estimates do not express or imply an obligation of the Government of Saskatchewan or the Ministry identified to accept or purchase any such items or goods whatsoever.
Award Documents:
Award Details
Abbvie Corporation
Saint-Laurent, QC
$2,031,102.00
The award amount specified is an estimate for the original 1 year term, and does not express or imply an obligation of the Government of Saskatchewan or the agencies identified to accept or purchase any such items or services whatsoever
Oct 28, 2020
Abbvie Corporation
|
Saint-Laurent, QC
|
$2,031,102.00
|
The award amount specified is an estimate for the original 1 year term, and does not express or imply an obligation of the Government of Saskatchewan or the agencies identified to accept or purchase any such items or services whatsoever
|
Oct 28, 2020
|
|
Oct 28, 2020 08:39 AM CST
|
|
Sep 15, 2020 04:15 PM CST
|
|
Sep 25, 2020 02:00 PM CST
|
Jeannie Munro
rfxquestions@gov.sk.ca
SaskBuilds
response@gov.sk.ca
Competition Information
Awarded
|
7816
|
Health
|
Synagis® (Palivizumab)
|
Advanced Contract Award Notice
|
No
|
The Competition detail was successfully retrieved. Jul 01, 2025 07:32 PM CST